|
Originally published In Press as doi:10.1074/jbc.R000028200 on November 28, 2000
J. Biol. Chem., Vol. 276, Issue 7, 4527-4530, February 16, 2001
MINIREVIEW
Dedicated Myosin Light Chain Kinases with Diverse Cellular
Functions*
Kristine E.
Kamm and
James T.
Stull
From the Department of Physiology, University of Texas Southwestern
Medical Center, Dallas, Texas 75390-9040
 |
INTRODUCTION |
Cell signaling events that lead to increased
[Ca2+]i1
in smooth and skeletal muscles activate
Ca2+/calmodulin-dependent MLCK. The kinase
phosphorylates a specific site on the N terminus of the RLC of the
molecular motor myosin II (1-3). RLC phosphorylation is sufficient to
initiate contraction in smooth muscle, but in striated muscles, RLC
phosphorylation potentiates the force and speed of contractions that
are dependent on Ca2+ binding to troponin on
actin-containing thin filaments. The only known physiological substrate
for MLCK is myosin RLC; thus, it is a dedicated protein kinase.
Interest in RLC phosphorylation has increased substantially with recent
reports implicating phosphorylation-dependent myosin II
activity in many functions of nonmuscle cells. These include cell
spreading and migration, neurite growth cone advancement, cytokinesis,
cytoskeletal clustering of integrins at focal adhesions, stress fiber
formation, platelet shape changes, secretion, transepithelial permeability, and cytoskeletal arrangements that affect ion currents or
exchange at the plasma membrane (4-8). The potential importance of RLC
phosphorylation in pathophysiological processes involving cell
migration is apparent, but less obvious involvements may include
cerebral vasospasm (9), increased endothelial permeability during
inflammation (10), and asthma (11).
 |
Myosin Light Chain Kinase Family |
In vertebrates there are two genes for MLCK (3). The skeletal
muscle MLCK gene encodes a kinase catalytic core and regulatory segment
containing autoinhibitory and Ca2+/calmodulin-binding
sequences (Fig. 1).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1.
A schematic of structural and functional
elements in myosin light chain kinase and related protein
kinases.
|
|
The smooth muscle MLCK gene expresses three transcripts in a
cell-specific manner due to alternate promoters (12-14). Smooth muscle
tissues normally have a short form of the kinase containing a catalytic
core and regulatory segment that differ in sequence and catalytic
specificity from skeletal muscle MLCK (Fig. 1). This kinase also
contains three Ig modules, one Fn module as well as a PEVK repeat-rich
region and an actin-binding sequence at the N terminus (Fig. 1). The Ig
and Fn modules have sandwich structures whereas the PEVK module is
responsible for the titin-dependent elastic properties of
striated muscle sarcomeres (15). The functions of these sequences in
MLCK are not clear. However, the actin-binding sequence is both
necessary and sufficient for high affinity binding in vitro
and in vivo (16, 17). Although it was proposed that the
actin-binding sequence resides in amino acids 1-41 of the short
isoform (17), more recent evidence demonstrates the importance of three
repeat motifs (DFRXXL) in residues 2-63, each of which may
bind a single actin monomer in an actin filament (18, 19). Thus, the N
terminus of MLCK may be anchored to actin thin filaments with extension
of the catalytic core to myosin thick filaments for RLC
phosphorylation. Smooth muscle MLCK is ubiquitous in all adult tissues
with the highest amounts in smooth muscle tissues whereas the skeletal
muscle kinase is tissue-specific (20).
Another transcript of the smooth muscle MLCK gene results in a longer
form of the kinase. It contains all of the shorter MLCK in addition to
an N-terminal extension with six Ig modules and two additional
actin-binding motifs in tandem (Fig. 1). The N-terminal extension may
be responsible for an increased affinity for actin-containing filaments
(21). This kinase is not normally expressed in adult smooth muscle
tissues but is found in smooth muscle cells in culture, in embryonic
smooth muscle tissue, and in nonmuscle cells (12, 22, 23). The longer
smooth muscle MLCK has been referred to as embryonic, nonmuscle,
endothelial cell or the 210-kDa MLCK. However, the short form is also
expressed in smooth muscle during embryogenesis and in some nonmuscle
cells; moreover, the long form is not restricted to endothelial cells
and is variable in size (20 kDa) in different animal species because of
the number of PEVK repeat sequences (3, 12, 22-24). We thus propose a simplified terminology of long and short smooth muscle MLCK, which could also accommodate recently reported alternatively spliced transcripts (80).
The third transcript of the smooth muscle MLCK gene is the C-terminal
Ig module, which results in the expression of the telokin protein in
phasic smooth muscle tissues (14). Telokin may contribute to
Ca2+ desensitization of smooth muscle force by cyclic
nucleotides (25).
Other kinases are related to the MLCK family (15). Titin, a molecular
template for sarcomere assembly and passive elasticity in vertebrate
striated muscles, contains a single kinase domain (26). The 3.0-mDa
titin polypeptide contains 132 Fn and 166 Ig modules (Fig. 1). The
titin kinase has a two-step activation mechanism involving tyrosine
phosphorylation in the active site followed by
Ca2+/calmodulin binding (26), leading to phosphorylation of
telethonin, a Z-disc protein required for sarcomere formation.
Kinases related to vertebrate skeletal and smooth muscle MLCKs are also
found in invertebrates. A single Drosophila gene produces from multiple internal promoters a number of transcripts with overlapping ends (15). Small transcripts (3.2-5.2 kb) encode kinase
proteins similar in size to the vertebrate MLCKs whereas larger
transcripts (13-25 kb) encode giant proteins similar to mammalian
titins. The largest 25-kb transcript encodes a 926-kDa stretchin MLCK
that has multiple structural modules (Fig. 1). Caenorhabditis elegans and Aplysia
express the related kinase, twitchin. The crystal structure of the
catalytic region of twitchin kinase shows an autoinhibitory segment
binding to the catalytic core. It does not contain a classical
calmodulin-binding sequence, but it is activated by the
Ca2+-binding protein, S100A12 (27). The
Dictyostelium MLCK is structurally the simplest related
kinase containing a catalytic core and a regulatory segment that must
be phosphorylated for activation (Fig. 1) (28).
 |
Activation by Ca2+/Calmodulin |
Upon complex formation with a calmodulin-binding peptide derived
from MLCK, Ca2+/calmodulin undergoes a conformational
collapse with its two domains wrapping around the peptide through the
bending of a flexible central helix (29-31). The calmodulin-binding
sequences of both smooth and skeletal muscle MLCKs then form an
amphiphilic -helix.
Kinetic and equilibrium studies of the binding interactions among
Ca2+, calmodulin, and MLCK, as well as small-angle x-ray
and neutron scattering results are consistent with an ordered sequence
of events culminating in MLCK activation (3, 24, 32-37). The autoinhibitory sequence folds back on the surface of the large lobe of
the MLCK catalytic core and prevents RLC but not ATP binding in the
catalytic cleft. Results from protein fragmentation complementation analyses indicate that the principal autoinhibitory motif is contained within the sequence between the catalytic core and the
calmodulin-binding sequence (36) consistent with previous results
obtained with truncation mutants (38). Residues C-terminal to the
calmodulin-binding sequence (including the Ig module) are not
functional components of the regulatory segment (36).
In the presence of Ca2+, the C-terminal domain of
calmodulin binds to the N terminus of the calmodulin-binding sequence
in MLCK with the subsequent binding of the N-terminal domain to the C terminus of the calmodulin-binding sequence (Fig.
2). Ensuing calmodulin interactions with
the catalytic core per se appear to be necessary for
activation (3, 33, 39, 40). Although calmodulin binding and activation
processes are basically similar for smooth and skeletal muscle MLCKs,
mutated calmodulins with abilities to activate one or the other kinase
indicated distinct differences in target-specific interactions (33,
41). The regulatory segment is subsequently displaced from the
catalytic site with calmodulin collapsed at a position near the end but adjacent to the catalytic core (Fig. 2). The exposed catalytic site of
the kinase allows the N terminus of RLC to bind with closure of the
cleft and transfer of phosphate from ATP to RLC resulting in the
reorientation of calmodulin.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Model for calmodulin activation of MLCK.
Calmodulin (A) is an elongated molecule that initially binds
with its C domain to the calmodulin-binding sequence of MLCK
(B). Calmodulin then collapses and translocates the
regulatory segment exposing the catalytic cleft (C). Binding
of substrates results in closure of the cleft and reorientation of
calmodulin. Calmodulin structures are shown in gold, modeled
structures of the kinase core are green, and the MLCK
calmodulin-binding peptide is blue. The
ellipsoids represent the structures of MLCK and calmodulin
obtained from x-ray and neutron scattering experiments (32, 35).
|
|
 |
Phosphorylation of Smooth Muscle MLCK in Vitro |
The activity of smooth muscle MLCK can be modulated by
phosphorylation at specific sites that lead to increased
KCaM or Vmax values (Fig.
3); however, both nonphosphorylated and
phosphorylated MLCKs are tightly regulated by
Ca2+/calmodulin binding, and no evidence exists for
physiologically relevant Ca2+/calmodulin-independent
activity. The most well documented effect of MLCK phosphorylation is a
10-fold increase in KCaM that occurs upon
phosphorylation of one of two serine residues in the C terminus of the
calmodulin-binding sequence. Several protein kinases phosphorylate this
site in vitro, including protein kinase A (42), protein kinase C (43), CaMK II (44), and PAK (45). MLCK contains several
phosphorylation consensus sites for proline-directed protein kinases,
and phosphorylation of either of two sites outside of the catalytic
core and regulatory segment by members of the MAPK family increases
Vmax with no change in
KCaM (46, 47).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
Schematic for regulation and modulation of
myosin II phosphorylation. Both
Ca2+/calmodulin-dependent MLCK and myosin
phosphatase activities are modified by phosphorylations resulting from
a network of cell signaling pathways. Myosin II phosphorylation
mediates a variety of cell responses. ERK, extracellular
signal-regulated kinase; PKA, protein kinase A;
PKC, protein kinase C; PKG, cGMP-dependent
protein kinase.
|
|
 |
Some Biological Functions of Smooth Muscle MLCKs |
Because of its dedicated nature, MLCK figures prominently in
efforts to define the regulation of actomyosin-dependent
functions in both smooth and nonmuscle cells where all isoforms of
myosin II are activated by RLC phosphorylation (2, 5). The extent of
RLC phosphorylation represents a balance between the relative activities of MLCK and myosin phosphatase, both of which are subject to
extensive regulation (Fig. 3).
Smooth Muscle--
In both intact and permeable smooth muscle
fibers, increases in [Ca2+]i result in increased
RLC phosphorylation and force (1, 2). The sufficiency of RLC
phosphorylation for contraction is shown by treatment of both intact
cells and skinned fibers with proteolytically activated MLCK in the
absence of elevated [Ca2+]i (2). The dependence
of force on steady state RLC phosphorylation is described by a unique
relation for most contractile and dilatory agents, with a few
exceptions that may point to thin filament-linked or other collateral
types of regulation (48). The dependence of RLC phosphorylation on
[Ca2+]i in differentiated smooth muscle arises
from the Ca2+/calmodulin-dependent activity of
short MLCK bound to myofilaments (49).
The sensitivity of RLC phosphorylation to [Ca2+]i
can be modulated by the action of different signaling pathways that modify MLCK or myosin phosphatase activities (Fig. 3). Ca2+
sensitization of RLC phosphorylation is observed where
[Ca2+]i remains constant and RLC phosphorylation
increases in response to application of agonists that lead to
GTP-dependent inhibition of myosin phosphatase (50). Smooth
muscle myosin phosphatase is a type 1 serine/threonine phosphatase
consisting of a 110-130-kDa myosin-binding subunit, a 37-kDa catalytic
subunit (PP1c), and a 20-kDa subunit with unknown function. Inhibition is effected by changes in subunit interactions occurring in response to
phosphorylation of the myosin-binding subunit by Rho kinase (51) or
other unidentified kinases (52). Inhibition can also be brought about
by the action of CPI-17 when phosphorylated by protein kinase C
(53).
Ca2+ desensitization of RLC phosphorylation occurs upon
phosphorylation of MLCK at the C terminus of the calmodulin-binding sequence and subsequent increase in KCaM.
Although the predominant response of smooth muscles to dilatory agents
such as -adrenergic agonists or nitric oxide is diminished
[Ca2+]i, inhibition of RLC phosphorylation can be
brought about without reductions in [Ca2+]i such
as when cAMP is elevated in depolarized muscles (54). In this case,
phosphorylation of MLCK is increased but not in the site that increases
KCaM (55, 56), suggesting that Ca2+
desensitization of RLC phosphorylation may result from the
cAMP-dependent activation of myosin phosphatase (25, 54,
55). Surprisingly, MLCK is phosphorylated on the C terminus of the
calmodulin-binding sequence in a Ca2+-dependent
manner during smooth muscle contractions by CaMK II, resulting in
desensitization of RLC phosphorylation to [Ca2+]i
(49, 55, 56). Although recent pharmacological studies with inhibitors
of CaMK II proposed MLCK phosphorylation did not contribute to
desensitization (57, 58), the observed decreases in force and RLC
phosphorylation likely arose from inhibition of CaMK II activity on
Ca2+ channels resulting in decreased
[Ca2+]i (59, 60). [Ca2+]i
thus acts in two ways to regulate
Ca2+-dependent RLC phosphorylation; it acts
positively to increase RLC phosphorylation by activating MLCK, and at
greater concentrations it acts negatively on RLC phosphorylation by
stimulating CaMK II phosphorylation of MLCK. MLCK is likely to be
dephosphorylated in vivo by myosin phosphatase as its
phosphorylation is potentiated by agents known to inhibit myosin
phosphatase such as agonists and GTP S (61). This may represent
feedback inhibition of the Rho-kinase-mediated Ca2+
sensitization pathway.
Nonmuscle Cells--
Phosphorylated myosin II is an important
effector of cytoskeletal activities in a number of cellular functions
(Fig. 3). Many of these functions arise in response to extracellular
signals that dictate temporally and spatially coordinate increases in [Ca2+]i and rearrangements of the actin
cytoskeleton (62). Ca2+-independent cell signaling pathways
also regulate target effectors including a host of actin-binding
proteins and the motor protein myosin II (4, 63). These pathways
generally couple ligand-bound receptors to the cytoskeleton through
activation of small GTP-binding proteins including Cdc42 and Rac with
effector kinases, PAK and MEK kinase, and Rho with its effector
kinase, Rho kinase (64). There is growing interest in the role of MLCK
in regulating myosin II ATPase activity during various motile processes
and modulation by these Ca2+-independent signaling
pathways. Some examples of these current topics follow.
Myosin II is regulated by the
Ca2+/calmodulin-dependent MLCK with the
necessary kinetic properties that dictate the rate and direction of
cell movement in response to temporally and spatially complex
extracellular signals. Photolysis of caged inhibitory peptides directed
to either calmodulin or MLCK results in blockade of cell locomotion,
granule flow, and forward motion of the leading lamellipod within a few
seconds in motile, polarized eosinophils (65). However, the formation
of phase dark ruffles and lamellar extensions, processes believed to be
dependent on actin polymerization, continues. In the smooth muscle cell
line SM3, decrease of MLCK by antisense mRNA inhibited both
motility and lamellipodia formation (66). Motility in eosinophils and
fibroblasts is associated with elevated [Ca2+]i,
and Ca2+/calmodulin-dependent MLCK appears to
be a major molecular control mechanism for cell locomotion (65).
However, these conclusions cannot be generalized to all locomoting
cells as polarization and chemotaxis occur in some cell types without
changes in [Ca2+]i (62).
Short and long isoforms of smooth muscle MLCK may have distinct
cellular functions. Fluorescence imaging of green fluorescent protein-tagged long MLCK showed this isoform to be localized to the cleavage furrow of dividing HeLa cells, whereas the green fluorescent protein-tagged short form was diffusely distributed in the
cytoplasm (67). Localization to the cleavage furrow required the five
actin-binding motifs and the N-terminal extension, whereas localization
of long or short MLCK to actin filaments during interphase required
only the actin-binding motifs.
MLCK activity may be modulated by signaling pathways known to regulate
cytoskeletal morphology. Phosphorylation of MLCK with an associated
decrease in RLC phosphorylation and disassembly of stress fibers was
observed in fibroblasts injected with cAMP-dependent protein kinase (68). These results are consistent with the well documented role of myosin II activity in stress fiber assembly (69) and
also with cAMP-mediated desensitization of MLCK (Fig. 3). Nevertheless,
some caution is warranted because of the findings that activation of
the cAMP pathway in smooth muscle did not increase KCaM (1, 3).
MLCK is also a target of the Rho family of GTPases in signaling to the
cytoskeleton (45, 70-72). MLCK phosphorylation by PAK is associated
with decreased MLCK activity, inhibition of RLC phosphorylation, and
inhibition of cell spreading or contraction (45, 70). PAK is strongly
implicated in cell locomotion, and other studies have shown that
constitutively activated PAK can induce motility/contractility and RLC
phosphorylation, potentially through its ability to phosphorylate
myosin RLC directly (71-73). The RhoA pathway leads to stress fiber
assembly and focal adhesion formation by inhibiting myosin phosphatase
activity and thereby enhancing RLC phosphorylation (4, 63).
Interestingly, Rho kinase may directly phosphorylate myosin RLC in
stress fibers whereas MLCK phosphorylates RLC in cortical actin bundles
in fibroblasts (74). It is clear from these and other studies that
localization of MLCK will play an important role in its biological functions.
The Ca2+ and calmodulin-dependent MLCK
signaling pathway may represent one of several parallel pathways for
regulation of myosin II activity in response to growth factors and
adhesion proteins. Treatment of MCF-7 breast cancer cells with uPA, an
activator of the MAPK pathway, stimulated cell migration,
phosphorylation of MLCK, and myosin RLC, all of which were inhibited by
a MEK inhibitor (75). These results are consistent with MAPK-mediated stimulation of MLCK activity by phosphorylation and resultant increases
in cell migration (46). Interestingly, the ability of uPA to stimulate
MCF-7 cell migration above basal values depended upon the engagement of
specific integrins; a second class of integrins stimulated migration
that was refractory to both uPA and MLCK inhibitors, indicating an
alternate signaling pathway (75).
Growth factor signaling may lead to tyrosine phosphorylation of MLCK
(76). The N terminus of long MLCK contains an SH2-binding domain and a
consensus tyrosine phosphorylation site for Src. Treatment of
endothelial cells with diperoxovanadate decreased barrier function and
was associated with Src binding to cortactin and tyrosine
phosphorylation of MLCK (77, 78). Long MLCK containing phosphotyrosine
was also isolated from fibroblasts transfected by constitutively
activated epidermal growth factor receptor, v-Erb-B (79).
 |
Concluding Remarks |
MLCK has served as a model for defining the enzyme activation
mechanism by the ubiquitous Ca2+ receptor, calmodulin, and
a wealth of biochemical, biophysical, and cellular information provides
insights into involved molecular processes. Recently identified
distinct isoforms of smooth muscle MLCK may regulate specific functions
of motility depending upon their respective intracellular locations and
Ca2+ sensitivities. The future holds exciting prospects for
identifying how networks of signaling pathways that regulate the actin
cytoskeleton control functionally important cellular properties of long
and short MLCKs.
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge advice and help
from Helen Yin, Anne Bresnick, Jill Trewhella, Joanna Krueger, and
Sheng Ye in the preparation of this manuscript.
 |
Note Added in Proof |
A recent report shows phosphorylation of
specific tyrosine residues in the N-terminal extension of long MLCK by
p60src increases kinase activity (81).
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 2001 Minireview Compendium, which
will be available in December, 2001. This is the fourth article of four in the
"Ca2+-dependent Cell Signaling through
Calmodulin-activated Protein Phosphatase and Protein Kinases Minireview
Series." The work from the authors was funded by the National
Institutes of Health.
To whom correspondence should be addressed. Tel.: 214-648-6849;
E-mail: James.Stull@UTSouthwestern.edu.
Published, JBC Papers in Press, November 28, 2000, DOI 10.1074/jbc.R000028200
 |
ABBREVIATIONS |
The abbreviations used are:
[Ca2+]i, intracellular calcium concentration;
MLCK, myosin light chain kinase;
RLC, regulatory light chain of myosin
II;
Fn, fibronectin;
PEVK, repeat sequences rich in Phe, Glu,
Val, and Lys residues;
kb, kilobase(s);
KCaM, concentration of Ca2+/calmodulin required for half-maximal
activation;
CaMK II, Ca2+/calmodulin-dependent
protein kinase II;
PAK, p21-activated kinase;
MAPK, mitogen-activated
protein kinase;
GTP S, guanosine
5'-3-O-(thio)triphosphate;
MEK, MAPK/extracellular
signal-regulated kinase kinase;
uPA, urokinase-type plasminogen
activator.
 |
REFERENCES |
| 1.
|
Kamm, K. E.,
and Stull, J. T.
(1985)
Annu. Rev. Pharmacol. Toxicol.
25,
593-620
|
| 2.
|
Hartshorne, D. J.
(1987)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed)
, pp. 423-482, Raven Press, New York
|
| 3.
|
Stull, J. T.,
Lin, P. J.,
Krueger, J. K.,
Trewhella, J.,
and Zhi, G.
(1998)
Acta Physiol. Scand.
164,
471-482
|
| 4.
|
Schoenwaelder, S. M.,
and Burridge, K.
(1999)
Curr. Opin. Cell Biol.
11,
274-286
|
| 5.
|
Bresnick, A. R.
(1999)
Curr. Opin. Cell Biol.
11,
26-33
|
| 6.
|
Szaszi, K.,
Kurashima, K.,
Kapus, A.,
Paulsen, A.,
Kaibuchi, K.,
Grinstein, S.,
and Orlowski, J.
(2000)
J. Biol. Chem.
275,
28599-28606
|
| 7.
|
Aromolaran, A. S.,
Albert, A. P.,
and Large, W. A.
(2000)
J. Physiol. (Lond.)
524,
853-863
|
| 8.
|
Tran, Q.-K.,
Watanabe, H.,
Zhang, X.-X.,
Takahashi, T.,
and Ohno, R.
(1999)
Cardiovasc. Res.
44,
623-631
|
| 9.
|
Sato, M.,
Tani, E.,
Fujikawa, H.,
and Kaibuchi, K.
(2000)
Circ. Res.
87,
195-200
|
| 10.
|
van Nieuw Amerongen, G. P.,
van Delft, S.,
Vermeer, M. A.,
Collard, J. G.,
and van Hinsbergh, V. W. M.
(2000)
Circ. Res.
87,
335-340
|
| 11.
|
Ammit, A. J.,
Armour, C. L.,
and Black, J. L.
(2000)
Am. J. Respir. Crit. Care Med.
161,
257-263
|
| 12.
|
Birukov, K. G.,
Schavocky, J. P.,
Shirinsky, V. P.,
Chibalina, M. V.,
Van Eldik, L. J.,
and Watterson, D. M.
(1998)
J. Cell. Biochem.
70,
402-413
|
| 13.
|
Watterson, D. M.,
Schavocky, J. P.,
Guo, L.,
Weiss, C.,
Chlenski, A.,
Shirinsky, V. P.,
Van Eldik, L. J.,
and Haiech, J.
(1999)
J. Cell. Biochem.
75,
481-491
|
| 14.
|
Smith, A. F.,
Bigsby, R. M.,
Word, R. A.,
and Herring, N. T.
(1998)
Am. J. Physiol.
274,
C1188-C1195
|
| 15.
|
Champagne, M. B.,
Edwards, K. A.,
Erickson, H. P.,
and Kiehart, D. P.
(2000)
J. Mol. Biol.
300,
759-777
|
| 16.
|
Lin, P.,
Luby-Phelps, K.,
and Stull, J. T.
(1999)
J. Biol. Chem.
274,
5987-5994
|
| 17.
|
Ye, L. H.,
Hayakawa, K.,
Kishi, H.,
Imamura, M.,
Nakamura, A.,
Okagaki, T.,
Takagi, T.,
Iwata, A.,
Tanaka, T.,
and Kohama, K.
(1997)
J. Biol. Chem.
272,
32182-32189
|
| 18.
|
Smith, L.,
Su, X.,
Lin, P.,
Zhi, G.,
and Stull, J. T.
(1999)
J. Biol. Chem.
274,
29433-29438
|
| 19.
|
Smith, L.,
and Stull, J. T.
(2000)
FEBS Lett.
480,
298-300
|
| 20.
|
Herring, B. P.,
Dixon, S.,
and Gallagher, P. J.
(2000)
Am. J. Physiol.
279,
C1656-C1664
|
| 21.
|
Kudryashov, D. S.,
Chibalina, M. V.,
Birukov, K. G.,
Lukas, T. J.,
Sellers, J. R.,
Van Eldik, L. J.,
Watterson, D. M.,
and Shirinsky, V. P.
(1999)
FEBS Lett.
463,
67-71
|
| 22.
|
Fisher, S. A.,
and Ikebe, M.
(1995)
Biochem. Biophys. Res. Commun.
217,
696-703
|
| 23.
|
Verin, A. D.,
Lazar, V.,
Torry, R. J.,
Labarrere, C. A.,
Patterson, C. E.,
and Garcia, J. G. N.
(1998)
Am. J. Respir. Cell Mol. Biol.
19,
758-766
|
| 24.
|
Gallagher, P. J.,
Herring, B. P.,
Griffin, S. A.,
and Stull, J. T.
(1991)
J. Biol. Chem.
266,
23936-23944
|
| 25.
|
Wu, X.,
Haystead, T. A.,
Nakamoto, R. K.,
Somlyo, A. V.,
and Somlyo, A. P.
(1998)
J. Biol. Chem.
273,
11362-11369
|
| 26.
|
Mayans, O.,
van der Ven, P. F.,
Wilm, M.,
Mues, A.,
Young, P.,
Furst, D. O.,
Wilmanns, M.,
and Gautel, M.
(1998)
Nature
395,
863-869
|
| 27.
|
Heierhorst, J.,
Kobe, B.,
Feil, S. C.,
Parker, M. W.,
Benian, G. M.,
Weiss, K. R.,
and Kemp, B. E.
(1996)
Nature
380,
636-639
|
| 28.
|
Smith, J. L.,
Silveira, L. A.,
and Spudich, J. A.
(1996)
EMBO J.
15,
6075-6083
|
| 29.
|
Heidorn, D. B.,
Seeger, P. A.,
Rokop, S. E.,
Blumenthal, D. K.,
Means, A. R.,
Crespi, H.,
and Trewhella, J.
(1989)
Biochemistry
28,
6757-6764
|
| 30.
|
Ikura, M.,
Clore, G. M.,
Gronenborn, A. M.,
Zhu, G.,
Klee, C. B.,
and Bax, A.
(1992)
Science
256,
632-638
|
| 31.
|
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1992)
Science
257,
1251-1255
|
| 32.
| Gallagher, S. C., Wall, M. E., Krueger, J. K., Stull,
J. T., and Trewhella, J. (2000) Biochemistry in
press
|
| 33.
|
Persechini, A.,
Yano, K.,
and Stemmer, P. M.
(2000)
J. Biol. Chem.
275,
4199-4204
|
| 34.
|
Bayley, P. M.,
Findlay, W. A.,
and Martin, S. R.
(1996)
Protein Sci.
5,
1215-1228
|
| 35.
|
Krueger, J. K.,
Zhi, G.,
Stull, J. T.,
and Trewhella, J.
(1998)
Biochemistry
37,
13997-14004
|
| 36.
|
Padre, R. C.,
and Stull, J. T.
(2000)
J. Biol. Chem.
275,
26665-26673
|
| 37.
|
Padre, R. C.,
and Stull, J. T.
(2000)
FEBS Lett.
472,
148-152
|
| 38.
|
Tanaka, M.,
Ikebe, R.,
Matsuura, M.,
and Ikebe, M.
(1995)
EMBO J.
14,
2839-2846
|
| 39.
|
Zhi, G.,
Abdullah, S. M.,
and Stull, J. T.
(1998)
J. Biol. Chem.
273,
8951-8957
|
| 40.
|
Chin, D.,
Schreiber, J. L.,
and Means, A. R.
(1999)
Biochemistry
38,
15061-15069
|
| 41.
|
Chin, D.,
and Means, A. R.
(2000)
Trends Cell Biol.
10,
322-328
|
| 42.
|
Conti, M. A.,
and Adelstein, R. S.
(1981)
J. Biol. Chem.
256,
3178-3181
|
| 43.
|
Nishikawa, M.,
Shirakawa, S.,
and Adelstein, R. S.
(1985)
J. Biol. Chem.
260,
8978-8983
|
| 44.
|
Hashimoto, Y.,
and Soderling, T. R.
(1990)
Arch. Biochem. Biophys.
278,
41-45
|
| 45.
|
Goeckeler, Z. M.,
Masaracchia, R. A.,
Zeng, Q.,
Chew, T. L.,
Gallagher, P.,
and Wysolmerski, R. B.
(2000)
J. Biol. Chem.
275,
18366-18374
|
| 46.
|
Klemke, R. L.,
Cai, S.,
Giannini, A. L.,
Gallagher, P. J.,
de Lanerolle, P.,
and Cheresh, D. A.
(1997)
J. Cell Biol.
137,
481-492
|
| 47.
|
Morrison, D. L.,
Sanghera, J. S.,
Stewart, J.,
Sutherland, C.,
Walsh, M. P.,
and Pelech, S. L.
(1996)
Biochem. Cell Biol.
74,
549-557
|
| 48.
|
McDaniel, N. L.,
Rembold, C. M.,
and Murphy, R. A.
(1994)
Can. J. Physiol. Pharmacol.
72,
1380-1385
|
| 49.
|
Tansey, M. G.,
Luby-Phelps, K.,
Kamm, K. E.,
and Stull, J. T.
(1994)
J. Biol. Chem.
269,
9912-9920
|
| 50.
|
Somlyo, A. P.,
and Somlyo, A. V.
(2000)
J. Physiol. (Lond.)
522,
177-185
|
| 51.
|
Kimura, K.,
Ito, M.,
Amano, M.,
Chihara, K.,
Fukata, Y.,
Nakafuku, M.,
Yamamori, B.,
Feng, J.,
Nakano, T.,
Okawa, K.,
Iwamatsu, A.,
and Kaibuchi, K.
(1996)
Science
273,
245-248
|
| 52.
|
Ichikawa, K.,
Ito, M.,
and Hartshorne, D. J.
(1996)
J. Biol. Chem.
271,
4733-4740
|
| 53.
|
Eto, M.,
Ohmori, T.,
Suzuki, M.,
Furuya, K.,
and Morita, F.
(1995)
J. Biochem. (Tokyo)
118,
1104-1107
|
| 54.
|
Kotlikoff, M. I.,
and Kamm, K. E.
(1996)
Annu. Rev. Physiol.
58,
115-141
|
| 55.
|
Tang, D. C.,
Stull, J. T.,
Kubota, Y.,
and Kamm, K. E.
(1992)
J. Biol. Chem.
267,
11839-11845
|
| 56.
|
Van Riper, D. A.,
Weaver, B. A.,
Stull, J. T.,
and Rembold, C. M.
(1995)
Am. J. Physiol.
268,
H2466-H2475
|
| 57.
|
Rokolya, A.,
and Singer, H. A.
(2000)
Am. J. Physiol.
278,
C537-C545
|
| 58.
|
Kim, I.,
Je, H. D.,
Gallant, C.,
Zhan, Q.,
Riper, D. V.,
Badwey, J. A.,
Singer, H. A.,
and Morgan, K. G.
(2000)
J. Physiol. (Lond.)
526,
367-374
|
| 59.
|
McCarron, J. G.,
McGeown, J. G.,
Reardon, S.,
Ikebe, M.,
Fay, F. S.,
and Walsh, J. V., Jr.
(1992)
Nature
357,
74-77
|
| 60.
|
Dzhura, I.,
Wu, Y.,
Colbran, R. J.,
Balser, J. R.,
and Anderson, M. E.
(2000)
Nat. Cell Biol.
2,
173-177
|
| 61.
|
Tang, D. C.,
Kubota, Y.,
Kamm, K. E.,
and Stull, J. T.
(1993)
FEBS Lett.
331,
272-275
|
| 62.
|
Pettit, E. J.,
and Fay, F. S.
(1998)
Physiol. Rev.
78,
949-967
|
| 63.
|
Kaibuchi, K.,
Kuroda, S.,
and Amano, M.
(1999)
Annu. Rev. Biochem.
68,
459-486
|
| 64.
|
Aspenstrom, P.
(1999)
Curr. Opin. Cell Biol.
11,
95-102
|
| 65.
|
Walker, J. W.,
Gilbert, S. H.,
Drummond, R. M.,
Yamada, M.,
Sreekumar, R.,
Carraway, R. E.,
Ikebe, M.,
and Fay, F. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1568-1573
|
| 66.
|
Kishi, H.,
Mikawa, T.,
Seto, M.,
Sasaki, Y.,
Kanayasu-Toyoda, T.,
Yamaguchi, T.,
Imamura, M.,
Ito, M.,
Karaki, H.,
Bao, J.,
Nakamura, A.,
Ishikawa, R.,
and Kohama, K.
(2000)
J. Biol. Chem.
275,
1414-1420
|
| 67.
|
Poperechnaya, A.,
Varlamova, O.,
Lin, P.-J.,
Stull, J. T.,
and Bresnick, A. R.
(2000)
J. Cell Biol.
151,
697-709
|
| 68.
|
Lamb, N. J.,
Fernandez, A.,
Conti, M. A.,
Adelstein, R.,
Glass, D. B.,
Welch, W. J.,
and Feramisco, J. R.
(1988)
J. Cell Biol.
106,
1955-1971
|
| 69.
|
Burridge, K.,
and Chrzanowska-Wodnicka, M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
463-518
|
| 70.
|
Sanders, L. C.,
Matsumura, F.,
Bokoch, G. M.,
and de Lanerolle, P.
(1999)
Science
283,
2083-2085
|
| 71.
|
Sells, M. A.,
Boyd, J. T.,
and Chernoff, J.
(1999)
J. Cell Biol.
145,
837-849
|
| 72.
|
Kiosses, W. B.,
Daniels, R. H.,
Otey, C.,
Bokoch, G. M.,
and Schwartz, M. A.
(1999)
J. Cell Biol.
147,
831-844
|
| 73.
|
Chew, T. L.,
Masaracchia, R. A.,
Goeckeler, Z. M.,
and Wysolmerski, R. B.
(1998)
J. Muscle Res. Cell Motil.
19,
839-854
|
| 74.
|
Totsukawa, G.,
Yamakita, Y.,
Yamashiro, S.,
Hartshorne, D. J.,
Sasaki, Y.,
and Matsumura, F.
(2000)
J. Cell Biol.
150,
797-806
|
| 75.
|
Nguyen, D. H.,
Catling, A. D.,
Webb, D. J.,
Sankovic, M.,
Walker, L. A.,
Somlyo, A. V.,
Weber, M. J.,
and Gonias, S. L.
(1999)
J. Cell Biol.
146,
149-164
|
| 76.
|
Cho, S. Y.,
and Klemke, R. L.
(2000)
J. Cell Biol.
149,
223-236
|
| 77.
|
Garcia, J. G.,
Verin, A. D.,
Schaphorst, K.,
Siddiqui, R.,
Patterson, C. E.,
Csortos, C.,
and Natarajan, V.
(1999)
Am. J. Physiol.
276,
L989-L998
|
| 78.
|
Shi, S.,
Garcia, J. G.,
Roy, S.,
Parinandi, N. L.,
and Natarajan, V.
(2000)
Am. J. Physiol.
279,
L441-L451
|
| 79.
|
McManus, M. J.,
Boerner, J. L.,
Danielsen, A. J.,
Wang, Z.,
Matsumura, F.,
and Maihle, N. J.
(2000)
J. Biol. Chem.
275,
35328-32334
|
| 80.
|
Lazar, V.,
and Garcia, J. G.
(1999)
Genomics
57,
256-267
|
| 81.
| Birukov, K. G., Csortos, C., Marzilli, L., Dudek, S., Ma, S-F.,
Bresnick, A. R., Verin, A. D., Cotter, R. J., and Garcia, J. G. N. (December 11, 2000) J. Biol. Chem. 10.1074/jbc.m005270200
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-L. Ding, J. W. Ryder, J. T. Stull, and K. E. Kamm
Signaling Processes for Initiating Smooth Muscle Contraction upon Neural Stimulation
J. Biol. Chem.,
June 5, 2009;
284(23):
15541 - 15548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Raina, J. Zacharia, M. Li, and W. G. Wier
Activation by Ca2+/calmodulin of an exogenous myosin light chain kinase in mouse arteries
J. Physiol.,
June 1, 2009;
587(11):
2599 - 2612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Wang, A. Nakamura, A. Matsumoto, S. Yoshiyama, X. Qin, L.-H. Ye, C. Xie, Y. Zhang, Y. Gao, R. Ishikawa, et al.
Nonkinase activity of MLCK in elongated filopodia formation and chemotaxis of vascular smooth muscle cells toward sphingosylphosphorylcholine
Am J Physiol Heart Circ Physiol,
May 1, 2009;
296(5):
H1683 - H1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Satoh, T. Morita, H. Takada, A. Kita, S. Ishiwata, A. Doi, K. Hagihara, A. Taga, Y. Matsumura, H. Tohda, et al.
Role of the RNA-binding Protein Nrd1 and Pmk1 Mitogen-activated Protein Kinase in the Regulation of Myosin mRNA Stability in Fission Yeast
Mol. Biol. Cell,
May 1, 2009;
20(9):
2473 - 2485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Jana, K.-Y. Kim, J. Mao, S. Kawamoto, J. R. Sellers, and R. S. Adelstein
An Alternatively Spliced Isoform of Non-muscle Myosin II-C Is Not Regulated by Myosin Light Chain Phosphorylation
J. Biol. Chem.,
April 24, 2009;
284(17):
11563 - 11571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Ratz and A. S. Miner
Role of Protein Kinase C{zeta} and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels
J. Pharmacol. Exp. Ther.,
February 1, 2009;
328(2):
399 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu, T. Ramjiganesh, Y.-H. Chen, S. W. Chung, S. R. Hall, S. L. Schissel, R. F. Padera Jr, R. Liao, K. G. Ackerman, J. Kajstura, et al.
Disruption of Striated Preferentially Expressed Gene Locus Leads to Dilated Cardiomyopathy in Mice
Circulation,
January 20, 2009;
119(2):
261 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Injeti, R. J. Sandoval, J. M. Williams, A. V. Smolensky, L. E. Ford, and W. J. Pearce
Maximal stimulation-induced in situ myosin light chain kinase activity is upregulated in fetal compared with adult ovine carotid arteries
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2289 - H2298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ponsaerts, C. D'hondt, G. Bultynck, S. P. Srinivas, J. Vereecke, and B. Himpens
The Myosin II ATPase Inhibitor Blebbistatin Prevents Thrombin-Induced Inhibition of Intercellular Calcium Wave Propagation in Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
November 1, 2008;
49(11):
4816 - 4827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. M. Goeckeler, P. C. Bridgman, and R. B. Wysolmerski
Nonmuscle myosin II is responsible for maintaining endothelial cell basal tone and stress fiber integrity
Am J Physiol Cell Physiol,
October 1, 2008;
295(4):
C994 - C1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Puchner, A. Alexandrovich, A. L. Kho, U. Hensen, L. V. Schafer, B. Brandmeier, F. Grater, H. Grubmuller, H. E. Gaub, and M. Gautel
Mechanoenzymatics of titin kinase
PNAS,
September 9, 2008;
105(36):
13385 - 13390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Lee, M.-H. Kim, W.-K. Ho, and S.-H. Lee
Presynaptic Release Probability and Readily Releasable Pool Size Are Regulated by Two Independent Mechanisms during Posttetanic Potentiation at the Calyx of Held Synapse
J. Neurosci.,
August 6, 2008;
28(32):
7945 - 7953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mizuno, E. Isotani, J. Huang, H. Ding, J. T. Stull, and K. E. Kamm
Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo
Am J Physiol Cell Physiol,
August 1, 2008;
295(2):
C358 - C364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Huang, J. M. Shelton, J. A. Richardson, K. E. Kamm, and J. T. Stull
Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy
J. Biol. Chem.,
July 11, 2008;
283(28):
19748 - 19756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Horman, N. Morel, D. Vertommen, N. Hussain, D. Neumann, C. Beauloye, N. E. Najjar, C. Forcet, B. Viollet, M. P. Walsh, et al.
AMP-activated Protein Kinase Phosphorylates and Desensitizes Smooth Muscle Myosin Light Chain Kinase
J. Biol. Chem.,
July 4, 2008;
283(27):
18505 - 18512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Takeya, K. Loutzenhiser, M. Shiraishi, R. Loutzenhiser, and M. P. Walsh
A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles
Am J Physiol Renal Physiol,
June 1, 2008;
294(6):
F1487 - F1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, J. J. Zhang, and X.-Y. Huang
cAMP Inhibits Cell Migration by Interfering with Rac-induced Lamellipodium Formation
J. Biol. Chem.,
May 16, 2008;
283(20):
13799 - 13805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Wier, M. A. Rizzo, H. Raina, and J. Zacharia
A technique for simultaneous measurement of Ca2+, FRET fluorescence and force in intact mouse small arteries
J. Physiol.,
May 15, 2008;
586(10):
2437 - 2443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Srinivasan, J. H. Kim, and H. von Gersdorff
The Pool of Fast Releasing Vesicles Is Augmented by Myosin Light Chain Kinase Inhibition at the Calyx of Held Synapse
J Neurophysiol,
April 1, 2008;
99(4):
1810 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Chilcoat, Y. Sharief, and S. L. Jones
Tonic protein kinase A activity maintains inactive {beta}2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase
J. Leukoc. Biol.,
April 1, 2008;
83(4):
964 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishikawa and R. Kurotani
Cardiac Myosin Light Chain Kinase: A New Player in the Regulation of Myosin Light Chain in the Heart
Circ. Res.,
March 14, 2008;
102(5):
516 - 518.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Chan, M. Takeda, L. E. Briggs, M. L. Graham, J. T. Lu, N. Horikoshi, E. O. Weinberg, H. Aoki, N. Sato, K. R. Chien, et al.
Identification of Cardiac-Specific Myosin Light Chain Kinase
Circ. Res.,
March 14, 2008;
102(5):
571 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Han and P. de Lanerolle
Naturally Extended CT {middle dot} AG Repeats Increase H-DNA Structures and Promoter Activity in the Smooth Muscle Myosin Light Chain Kinase Gene
Mol. Cell. Biol.,
January 15, 2008;
28(2):
863 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. Weigand, J. Foxson, L. A. Shimoda, and J. T. Sylvester
Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L674 - L685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wei, S. da Rocha Dias, H. Wang, and C. E. Rudd
CTL-Associated Antigen-4 Ligation Induces Rapid T Cell Polarization That Depends on Phosphatidylinositol 3-Kinase, Vav-1, Cdc42, and Myosin Light Chain Kinase
J. Immunol.,
July 1, 2007;
179(1):
400 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Guo, M. Satpathy, G. Wilson, and S. P. Srinivas
Benzalkonium Chloride Induces Dephosphorylation of Myosin Light Chain in Cultured Corneal Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
May 1, 2007;
48(5):
2001 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D'hondt, S. P. Srinivas, J. Vereecke, and B. Himpens
Adenosine Opposes Thrombin-Induced Inhibition of Intercellular Calcium Wave in Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
April 1, 2007;
48(4):
1518 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshioka, N. Sugimoto, N. Takuwa, and Y. Takuwa
Essential Role for Class II Phosphoinositide 3-kinase {alpha}-Isoform in Ca2+-Induced, Rho- and Rho Kinase-Dependent Regulation of Myosin Phosphatase and Contraction in Isolated Vascular Smooth Muscle Cells
Mol. Pharmacol.,
March 1, 2007;
71(3):
912 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Lincoln
Myosin Phosphatase Regulatory Pathways: Different Functions or Redundant Functions?
Circ. Res.,
January 5, 2007;
100(1):
10 - 12.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D'hondt, R. Ponsaerts, S. P. Srinivas, J. Vereecke, and B. Himpens
Thrombin Inhibits Intercellular Calcium Wave Propagation in Corneal Endothelial Cells by Modulation of Hemichannels and Gap Junctions
Invest. Ophthalmol. Vis. Sci.,
January 1, 2007;
48(1):
120 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Huang, H. Zhou, S. Mahavadi, W. Sriwai, and K. S. Murthy
Inhibition of G{alpha}q-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C200 - C208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jin, E. K. Blue, and P. J. Gallagher
Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal Degradation
J. Biol. Chem.,
December 22, 2006;
281(51):
39033 - 39040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Turner
Molecular Basis of Epithelial Barrier Regulation: From Basic Mechanisms to Clinical Application
Am. J. Pathol.,
December 1, 2006;
169(6):
1901 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tokuoka and Y. Goda
Myosin Light Chain Kinase Is Not a Regulator of Synaptic Vesicle Trafficking during Repetitive Exocytosis in Cultured Hippocampal Neurons.
J. Neurosci.,
November 8, 2006;
26(45):
11606 - 11614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Herring, O. El-Mounayri, P. J. Gallagher, F. Yin, and J. Zhou
Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues
Am J Physiol Cell Physiol,
November 1, 2006;
291(5):
C817 - C827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. V. Graham, F. Wang, D. R. Clayburgh, J. X. Cheng, B. Yoon, Y. Wang, A. Lin, and J. R. Turner
Tumor Necrosis Factor-induced Long Myosin Light Chain Kinase Transcription Is Regulated by Differentiation-dependent Signaling Events: CHARACTERIZATION OF THE HUMAN LONG MYOSIN LIGHT CHAIN KINASE PROMOTER
J. Biol. Chem.,
September 8, 2006;
281(36):
26205 - 26215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Srinivas, M. Satpathy, Y. Guo, and V. Anandan
Histamine-Induced Phosphorylation of the Regulatory Light Chain of Myosin II Disrupts the Barrier Integrity of Corneal Endothelial Cells.
Invest. Ophthalmol. Vis. Sci.,
September 1, 2006;
47(9):
4011 - 4018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Connell and D. M. Helfman
Myosin light chain kinase plays a role in the regulation of epithelial cell survival
J. Cell Sci.,
June 1, 2006;
119(11):
2269 - 2281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Yin, A. M. Hoggatt, J. Zhou, and B. P. Herring
130-kDa smooth muscle myosin light chain kinase is transcribed from a CArG-dependent, internal promoter within the mouse mylk gene
Am J Physiol Cell Physiol,
June 1, 2006;
290(6):
C1599 - C1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Vijayan and P. F. Bray
Molecular Mechanisms of Prothrombotic Risk Due to Genetic Variations in Platelet Genes: Enhanced Outside-In Signaling Through the Pro33 Variant of Integrin {beta}3.
Experimental Biology and Medicine,
May 1, 2006;
231(5):
505 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Woodsome, A. Polzin, K. Kitazawa, M. Eto, and T. Kitazawa
Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells
J. Cell Sci.,
May 1, 2006;
119(9):
1769 - 1780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Crawley, M. A. de la Roche, S.-F. Lee, Z. Li, S. Chitayat, S. P. Smith, and G. P. Cote
Identification and Characterization of an 8-kDa Light Chain Associated with Dictyostelium discoideum MyoB, a Class I Myosin
J. Biol. Chem.,
March 10, 2006;
281(10):
6307 - 6315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Khromov, H. Wang, N. Choudhury, M. McDuffie, B. P. Herring, R. Nakamoto, G. K. Owens, A. P. Somlyo, and A. V. Somlyo
Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation
PNAS,
February 14, 2006;
103(7):
2440 - 2445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shimizu, T. Yoshida, M. Wakamori, M. Ishii, T. Okada, M. Takahashi, M. Seto, K. Sakurada, Y. Kiuchi, and Y. Mori
Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells
J. Physiol.,
January 15, 2006;
570(2):
219 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Melton, A. Datta, and H. F. Yee Jr.
[Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1
Am J Physiol Gastrointest Liver Physiol,
January 1, 2006;
290(1):
G7 - G13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Matson, S. Markoulaki, and T. Ducibella
Antagonists of Myosin Light Chain Kinase and of Myosin II Inhibit Specific Events of Egg Activation in Fertilized Mouse Eggs
Biol Reprod,
January 1, 2006;
74(1):
169 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ohlmann, A. Tesse, C. Loichot, H. R. Ranaivo, G. Roul, C. Philippe, D. M. Watterson, J. Haiech, and R. Andriantsitohaina
Deletion of MLCK210 induces subtle changes in vascular reactivity but does not affect cardiac function
Am J Physiol Heart Circ Physiol,
December 1, 2005;
289(6):
H2342 - H2349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhi, J. W. Ryder, J. Huang, P. Ding, Y. Chen, Y. Zhao, K. E. Kamm, and J. T. Stull
Myosin light chain kinase and myosin phosphorylation effect frequency-dependent potentiation of skeletal muscle contraction
PNAS,
November 29, 2005;
102(48):
17519 - 17524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Vicari, B. Chaitman, D. Keefe, W. B. Smith, S. G. Chrysant, M. J. Tonkon, N. Bittar, R. J. Weiss, H. Morales-Ballejo, U. Thadani, et al.
Efficacy and Safety of Fasudil in Patients With Stable Angina: A Double-Blind, Placebo-Controlled, Phase 2 Trial
J. Am. Coll. Cardiol.,
November 15, 2005;
46(10):
1803 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. M. Goeckeler and R. B. Wysolmerski
Myosin Phosphatase and Cofilin Mediate cAMP/cAMP-dependent Protein Kinase-induced Decline in Endothelial Cell Isometric Tension and Myosin II Regulatory Light Chain Phosphorylation
J. Biol. Chem.,
September 23, 2005;
280(38):
33083 - 33095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-B. Kim, J. Yu, S.-Y. Lee, M.-S. Lee, S.-G. Ko, S.-K. Ye, H.-S. Jong, T.-Y. Kim, Y.-J. Bang, and J. W. Lee
Cell Adhesion Status-dependent Histone Acetylation Is Regulated through Intracellular Contractility-related Signaling Activities
J. Biol. Chem.,
August 5, 2005;
280(31):
28357 - 28364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Qvigstad, I. Sjaastad, T. Brattelid, C. Nunn, F. Swift, J. A. K. Birkeland, K. A. Krobert, G. O. Andersen, O. M. Sejersted, J.-B. Osnes, et al.
Dual Serotonergic Regulation of Ventricular Contractile Force Through 5-HT2A and 5-HT4 Receptors Induced in the Acute Failing Heart
Circ. Res.,
August 5, 2005;
97(3):
268 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yang and X.-Y. Huang
Ca2+ Influx through L-type Ca2+ Channels Controls the Trailing Tail Contraction in Growth Factor-induced Fibroblast Cell Migration
J. Biol. Chem.,
July 22, 2005;
280(29):
27130 - 27137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Vijayan, Y. Liu, W. Sun, M. Ito, and P. F. Bray
The Pro33 Isoform of Integrin {beta}3 Enhances Outside-in Signaling in Human Platelets by Regulating the Activation of Serine/Threonine Phosphatases
J. Biol. Chem.,
June 10, 2005;
280(23):
21756 - 21762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Goggel and S. Uhlig
The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema
Eur. Respir. J.,
May 1, 2005;
25(5):
849 - 857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Ratz, K. M. Berg, N. H. Urban, and A. S. Miner
Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus
Am J Physiol Cell Physiol,
April 1, 2005;
288(4):
C769 - C783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ekman, K. Fagher, M. Wede, K. Stakeberg, and A. Arner
Decreased Phosphatase Activity, Increased Ca2+ Sensitivity, and Myosin Light Chain Phosphorylation in Urinary Bladder Smooth Muscle of Newborn Mice
J. Gen. Physiol.,
January 31, 2005;
125(2):
187 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Clayburgh, S. Rosen, E. D. Witkowski, F. Wang, S. Blair, S. Dudek, J. G. N. Garcia, J. C. Alverdy, and J. R. Turner
A Differentiation-dependent Splice Variant of Myosin Light Chain Kinase, MLCK1, Regulates Epithelial Tight Junction Permeability
J. Biol. Chem.,
December 31, 2004;
279(53):
55506 - 55513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shi, E. Mori, Y. Mori, M. Mori, J. Li, Y. Ito, and R. Inoue
Multiple regulation by calcium of murine homologues of transient receptor potential proteins TRPC6 and TRPC7 expressed in HEK293 cells
J. Physiol.,
December 1, 2004;
561(2):
415 - 432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chou, B. M. Christensen, S. Frische, H. Vorum, R. A. Desai, J. D. Hoffert, P. de Lanerolle, S. Nielsen, and M. A. Knepper
Non-muscle Myosin II and Myosin Light Chain Kinase Are Downstream Targets for Vasopressin Signaling in the Renal Collecting Duct
J. Biol. Chem.,
November 19, 2004;
279(47):
49026 - 49035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hartshorne, M. Ito, and F. Erdodi
Role of Protein Phosphatase Type 1 in Contractile Functions: Myosin Phosphatase
J. Biol. Chem.,
September 3, 2004;
279(36):
37211 - 37214.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kim, W. Cao, I. S. Song, C. Y. Kim, K. M. Harnett, L. Cheng, M. P. Walsh, and P. Biancani
Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles
Am J Physiol Cell Physiol,
August 1, 2004;
287(2):
C384 - C394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-D. Ren, R. Wang, Q. Li, L. A. F. Kahek, K. Kaibuchi, and R. A. F. Clark
Disruption of Rho signal transduction upon cell detachment
J. Cell Sci.,
July 15, 2004;
117(16):
3511 - 3518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zaugg and M. C. Schaub
Cellular mechanisms in sympatho-modulation of the heart
Br. J. Anaesth.,
July 1, 2004;
93(1):
34 - 52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Dudek, J. R. Jacobson, E. T. Chiang, K. G. Birukov, P. Wang, X. Zhan, and J. G. N. Garcia
Pulmonary Endothelial Cell Barrier Enhancement by Sphingosine 1-Phosphate: ROLES FOR CORTACTIN AND MYOSIN LIGHT CHAIN KINASE
J. Biol. Chem.,
June 4, 2004;
279(23):
24692 - 24700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Isotani, G. Zhi, K. S. Lau, J. Huang, Y. Mizuno, A. Persechini, R. Geguchadze, K. E. Kamm, and J. T. Stull
Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse
PNAS,
April 20, 2004;
101(16):
6279 - 6284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iwabu, K. Smith, F. D. Allen, D. A. Lauffenburger, and A. Wells
Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C {delta}-dependent Pathway
J. Biol. Chem.,
April 9, 2004;
279(15):
14551 - 14560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Dulyaninova, Y. V. Patskovsky, and A. R. Bresnick
The N-terminus of the long MLCK induces a disruption in normal spindle morphology and metaphase arrest
J. Cell Sci.,
March 15, 2004;
117(8):
1481 - 1493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Polo-Parada, C. M. Bose, F. Plattner, and L. T. Landmesser
Distinct Roles of Different Neural Cell Adhesion Molecule (NCAM) Isoforms in Synaptic Maturation Revealed by Analysis of NCAM 180 kDa Isoform-Deficient Mice
J. Neurosci.,
February 25, 2004;
24(8):
1852 - 1864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Totsukawa, Y. Wu, Y. Sasaki, D. J. Hartshorne, Y. Yamakita, S. Yamashiro, and F. Matsumura
Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts
J. Cell Biol.,
February 2, 2004;
164(3):
427 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tokumitsu, N. Hatano, H. Inuzuka, Y. Ishikawa, T. Q. P. Uyeda, J. L. Smith, and R. Kobayashi
Regulatory Mechanism of Dictyostelium Myosin Light Chain Kinase A
J. Biol. Chem.,
January 2, 2004;
279(1):
42 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. CEULEMANS and M. BOLLEN
Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button
Physiol Rev,
January 1, 2004;
84(1):
1 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Munevar, Y.-l. Wang, and M. Dembo
Regulation of mechanical interactions between fibroblasts and the substratum by stretch-activated Ca2+ entry
J. Cell Sci.,
January 1, 2004;
117(1):
85 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Emmert, J. A. Fee, Z. M. Goeckeler, J. M. Grojean, T. Wakatsuki, E. L. Elson, B. P. Herring, P. J. Gallagher, and R. B. Wysolmerski
Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts
Am J Physiol Cell Physiol,
January 1, 2004;
286(1):
C8 - C21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Qin, B. Raught, N. Sonenberg, E. G. Goldstein, and A. M. Edelman
Phosphorylation Screening Identifies Translational Initiation Factor 4GII as an Intracellular Target of Ca2+/Calmodulin-dependent Protein Kinase I
J. Biol. Chem.,
December 5, 2003;
278(49):
48570 - 48579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abe, C.-H. Ho, K. E. Kamm, and F. Grinnell
Different Molecular Motors Mediate Platelet-derived Growth Factor and Lysophosphatidic Acid-stimulated Floating Collagen Matrix Contraction
J. Biol. Chem.,
November 28, 2003;
278(48):
47707 - 47712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Schuh, T. Quaschning, S. Knauer, K. Hu, S. Kocak, N. Roethlein, and L. Neyses
Regulation of Vascular Tone in Animals Overexpressing the Sarcolemmal Calcium Pump
J. Biol. Chem.,
October 17, 2003;
278(42):
41246 - 41252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. ROSENFELDT, Y. AMRANI, K. R. WATTERSON, K. S. MURTHY, R. A. PANETTIERI JR, and S. SPIEGEL
Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells
FASEB J,
October 1, 2003;
17(13):
1789 - 1799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. SOMLYO and A. V. SOMLYO
Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
Physiol Rev,
October 1, 2003;
83(4):
1325 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Birukov, J. R. Jacobson, A. A. Flores, S. Q. Ye, A. A. Birukova, A. D. Verin, and J. G. N. Garcia
Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch
Am J Physiol Lung Cell Mol Physiol,
October 1, 2003;
285(4):
L785 - L797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Bornhauser, P.-A. Olsson, and D. Lindholm
MSAP Is a Novel MIR-interacting Protein That Enhances Neurite Outgrowth and Increases Myosin Regulatory Light Chain
J. Biol. Chem.,
September 12, 2003;
278(37):
35412 - 35420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Funabara, S. Watabe, S. U. Mooers, S. Narayan, C. Dudas, D. J. Hartshorne, M. J. Siegman, and T. M. Butler
Twitchin from Molluscan Catch Muscle: PRIMARY STRUCTURE AND RELATIONSHIP BETWEEN SITE-SPECIFIC PHOSPHORYLATION AND MECHANICAL FUNCTION
J. Biol. Chem.,
August 1, 2003;
278(31):
29308 - 29316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Smith, M. Bracke, B. Leitinger, J. C. Porter, and N. Hogg
LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment
J. Cell Sci.,
August 1, 2003;
116(15):
3123 - 3133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wrayzx, K. Jones, S. Kupittayanant, Y. Li, A. Matthew, E. Monir-Bishty, K. Noble, S. J. Pierce, S. Quenby, and A. V. Shmygol
Calcium Signaling and Uterine Contractility
Reproductive Sciences,
July 1, 2003;
10(5):
252 - 264.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Murthy, H. Zhou, J. R. Grider, and G. M. Makhlouf
Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA
Am J Physiol Gastrointest Liver Physiol,
June 1, 2003;
284(6):
G1006 - G1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Rudrabhatla, S. K. Sukumaran, G. M. Bokoch, and N. V. Prasadarao
Modulation of Myosin Light-Chain Phosphorylation by p21-Activated Kinase 1 in Escherichia coli Invasion of Human Brain Microvascular Endothelial Cells
Infect. Immun.,
May 1, 2003;
71(5):
2787 - 2797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Schulz, A. D. McIntosh, M. R. Kasten, B. Wieringa, and H. F. Epstein
A Role for Myotonic Dystrophy Protein Kinase in Synaptic Plasticity
J Neurophysiol,
March 1, 2003;
89(3):
1177 - 1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Vijayan, Y. Liu, J.-F. Dong, and P. F. Bray
Enhanced Activation of Mitogen-activated Protein Kinase and Myosin Light Chain Kinase by the Pro33 Polymorphism of Integrin beta 3
J. Biol. Chem.,
January 31, 2003;
278(6):
3860 - 3867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Garcia-Garcia and C. Rosales
Signal transduction during Fc receptor-mediated phagocytosis
J. Leukoc. Biol.,
December 1, 2002;
72(6):
1092 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Smith, M. Parizi-Robinson, M.-S. Zhu, G. Zhi, R. Fukui, K. E. Kamm, and J. T. Stull
Properties of Long Myosin Light Chain Kinase Binding to F-Actin in Vitro and in Vivo
J. Biol. Chem.,
September 13, 2002;
277(38):
35597 - 35604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bao, K. Oishi, T. Yamada, L. Liu, A. Nakamura, M. K. Uchida, and K. Kohama
Role of the short isoform of myosin light chain kinase in the contraction of cultured smooth muscle cells as examined by its down-regulation
PNAS,
July 9, 2002;
99(14):
9556 - 9561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishikawa, H. Iida, and H. Ishida
The Muscarinic Acetylcholine Receptor-Stimulated Increase in Aquaporin-5 Levels in the Apical Plasma Membrane in Rat Parotid Acinar Cells Is Coupled with Activation of Nitric Oxide/cGMP Signal Transduction
Mol. Pharmacol.,
June 1, 2002;
61(6):
1423 - 1434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Van Lierop, D. P. Wilson, J. P. Davis, S. Tikunova, C. Sutherland, M. P. Walsh, and J. D. Johnson
Activation of Smooth Muscle Myosin Light Chain Kinase by Calmodulin. ROLE OF LYS30 and GLY40
J. Biol. Chem.,
February 15, 2002;
277(8):
6550 - 6558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lei, E. Czerwinska, W. Czerwinski, M. P. Walsh, and J. F. MacDonald
Regulation of NMDA Receptor Activity by F-Actin and Myosin Light Chain Kinase
J. Neurosci.,
November 1, 2001;
21(21):
8464 - 8472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jin, E. K. Blue, S. Dixon, L. Hou, R. B. Wysolmerski, and P. J Gallagher
Identification of a New Form of Death-associated Protein Kinase That Promotes Cell Survival
J. Biol. Chem.,
October 19, 2001;
276(43):
39667 - 39678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Ansari, S. Husain, and A. A. Abdel-Latif
Activation of p42/p44 Mitogen-Activated Protein Kinase and Contraction by Prostaglandin F2alpha , Ionomycin, and Thapsigargin in Cat Iris Sphincter Smooth Muscle: Inhibition by PD98059, KN-93, and Isoproterenol
J. Pharmacol. Exp. Ther.,
October 1, 2001;
299(1):
178 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pfitzer
Signal Transduction in Smooth Muscle: Invited Review: Regulation of myosin phosphorylation in smooth muscle
J Appl Physiol,
July 1, 2001;
91(1):
497 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Eto, T. Kitazawa, M. Yazawa, H. Mukai, Y. Ono, and D. L. Brautigan
Histamine-induced Vasoconstriction Involves Phosphorylation of a Specific Inhibitor Protein for Myosin Phosphatase by Protein Kinase C alpha and delta Isoforms
J. Biol. Chem.,
July 27, 2001;
276(31):
29072 - 29078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Wilson, C. Sutherland, and M. P. Walsh
Ca2+ Activation of Smooth Muscle Contraction. EVIDENCE FOR THE INVOLVEMENT OF CALMODULIN THAT IS BOUND TO THE TRITON-INSOLUBLE FRACTION EVEN IN THE ABSENCE OF Ca2+
J. Biol. Chem.,
January 11, 2002;
277(3):
2186 - 2192.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|